Brokerages Set Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Price Target at $23.17
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) has earned an average recommendation of “Buy” from the eight brokerages that are currently covering the firm, Marketbeat.com reports. Eight analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have issued ratings on the stock in the last year […]
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) has earned an average recommendation of “Buy” from the eight brokerages that are currently covering the firm, Marketbeat.com reports. Eight analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have issued ratings on the stock in the last year […]
